Clinical Trial Update: A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 2]

View source ↗

Summary

A Phase II study evaluated whether trabodenoson adds to latanoprost in adults with ocular hypertension or primary open-angle glaucoma, and the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Trabodenoson (trabodenoson)

Snippet

Sponsor: Inotek Pharmaceuticals Corporation | Conditions: Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 2 | Status: COMPLETED